XIAP CRISPR Plasmids (h) human XIAP-specific CRISPR/Cas9 KO Plasmid, HDR Plasmid, Double Nickase Plasmids, CRISPR Activation Plasmids and Lentiviral Activation Particles

XIAP CRISPR Plasmids (h)

XIAP CRISPR Knockout and Activation Products (h) is rated 5.0 out of 5 by 2.
  • y_2020, m_4, d_4, h_21
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.5
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_2
  • loc_en_US, sid_416497, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 139ms
  • REVIEWS, PRODUCT
5
2
4
0
3
0
2
0
1
0

Datasheets

    • Target species: human; for corresponding mouse product, see XIAP CRISPR Plasmids (m)
    • CRISPR/Cas9 KO Plasmids consists of XIAP-specific 20 nt guide RNA sequences derived from the GeCKO (v2) library
    • For CRISPR gene knockout, gRNA sequences direct the Cas9 protein to induce a site-specific double strand break (DSB) in the genomic DNA
    • Target-specific CRISPR Plasmids for both gene knockout and activation are available. Please refer to the detailed product information in the tabs below
    • Gene knockdown or activation can be assayed using XIAP Antibody (A-7): sc-55550
    • All products are provided as transfection-ready, purified plasmid DNA, except the Lentiviral Activation Particles which have been prepackaged as Lentiviral Particles for use with hard-to-transfect cells
Submit a review for this product and receive 15 CruzCredits

Gene Info

SpeciesGene NameGene IDChromosome LocationIsoform (mRNA) Accession #Protein Accession #OMIM™ Number
HumanXIAP331Xq25XM_006724754, XM_011531329, NM_001167, NM_001204401P98170300635
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 121ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from So far So far, we have produced clones in human MDA231 breast cancer cells and, as control, in HEK293 cells. We have a 100% success rate wrt XIAP loss, with variable RFP expression we are analyzing more clones but we are already very happy with this has turned out this sets the stage for some very interesting experiments!
Date published: 2015-03-20
Rated 5 out of 5 by from So far So far, we have produced clones in human MDA231 breast cancer cells and, as control, in HEK293 cells. We have a 100% success rate wrt XIAP loss, with variable RFP expression we are analyzing more clones but we are already very happy with this has turned out this sets the stage for some very interesting experiments!
Date published: 2015-03-20
  • y_2020, m_4, d_4, h_21
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.5
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_2
  • loc_en_US, sid_416497, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 21ms
  • REVIEWS, PRODUCT

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.